Literature DB >> 11473484

Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins.

C L Elsegood1, S Pal, P D Roach, J C Mamo.   

Abstract

The binding and uptake of chylomicron remnants by human macrophages was studied in order to resolve paradoxical observations that have described the putative mechanisms by which postprandial lipoproteins induce foam cell formation. Chylomicron remnants bound to human monocyte-derived macrophages (HMMs) and to the transformed monocytic cell line THP-1 with high affinity (Kd of approx. 5.5 microg of chylomicron remnant protein/ml). Binding was found to be saturable for both cell types, and was strongly inhibited in the presence of unlabelled chylomicron remnants. Ligand blot studies with colloidal-gold-labelled chylomicron remnants identified two cell surface binding sites on both HMMs and THP-1 cells, with molecular masses of approx. 128 kDa and 43 kDa. The high-molecular-mass binding site was found to be the low-density lipoprotein (LDL) receptor, based on the strong inhibition of chylomicron remnant binding in the presence of unlabelled LDL, Fab2 antibody fragments to the LDL receptor or calcium chelators. Competition studies suggested that, in HMMs, the LDL receptor appeared to facilitate approximately half of the total chylomicron remnant uptake. In contrast, the LDL receptor was not significantly involved in macrophage uptake of chylomicron remnants by THP-1 cells. The identity of the 43 kDa binding site is presently unknown, but, importantly, expression was not inhibited as a consequence of sterol loading, which was induced by incubating HMMs and THP-1 cells with 25-hydroxycholesterol. In contrast, the expression of the LDL receptor was substantially attenuated following lipid loading. Collectively, our data suggest that, while the macrophage LDL receptor can bind chylomicron remnants and facilitate uptake in non-lipid-loaded HMMs, other sterol-insensitive sites are responsible for the unabated uptake of chylomicron remnants by macrophages. We propose that the 43 kDa macrophage chylomicron remnant binding protein may be a candidate for the sterol loading of macrophages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473484

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect FA translocation.

Authors:  Anthony G Jay; Jeffrey R Simard; Nasi Huang; James A Hamilton
Journal:  J Lipid Res       Date:  2020-02-26       Impact factor: 5.922

Review 2.  The iterative lipid impact on inflammation in atherosclerosis.

Authors:  Jordan M Kraaijenhof; G Kees Hovingh; Erik S G Stroes; Jeffrey Kroon
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

3.  The chylomicron: relationship to atherosclerosis.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  Int J Vasc Med       Date:  2011-10-05

Review 4.  Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins.

Authors:  Sameer Ansar; Juraj Koska; Peter D Reaven
Journal:  Cardiovasc Diabetol       Date:  2011-07-07       Impact factor: 9.951

5.  Phospholipase A2 mediates apolipoprotein-independent uptake of chylomicron remnant-like particles by human macrophages.

Authors:  Mariarosaria Napolitano; Howard S Kruth; Elena Bravo
Journal:  Int J Vasc Med       Date:  2011-08-21

Review 6.  Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment.

Authors:  Hidekatsu Yanai; Hiroki Adachi; Mariko Hakoshima; Hisayuki Katsuyama
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

7.  Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes.

Authors:  Fatos Bejta; Elizabeth H Moore; Michael Avella; Peter J Gough; Keith E Suckling; Kathleen M Botham
Journal:  Biochim Biophys Acta       Date:  2007-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.